Uni-Bio Science Group Limited
UNBSF
$0.004
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.01% | 6.40% | 10.11% | 17.56% | 25.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.01% | 6.40% | 10.11% | 17.56% | 25.67% |
| Cost of Revenue | -20.30% | -16.52% | -12.83% | -1.60% | 10.64% |
| Gross Profit | 9.32% | 13.07% | 17.33% | 23.64% | 30.48% |
| SG&A Expenses | -6.50% | 1.90% | 11.54% | 16.73% | 21.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -25.25% | -50.77% | -75.85% | -8.79% | 34.98% |
| Total Operating Expenses | -4.99% | -1.20% | 2.76% | 6.35% | 9.82% |
| Operating Income | 49.05% | 57.81% | 71.27% | 170.25% | 645.00% |
| Income Before Tax | 46.07% | 57.17% | 75.37% | 314.69% | 1,021.66% |
| Income Tax Expenses | -35.93% | -20.70% | 5.20% | 227.35% | 1,178.04% |
| Earnings from Continuing Operations | 56.60% | 67.03% | 84.07% | 325.84% | 1,004.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.60% | 67.03% | 84.07% | 325.84% | 1,004.71% |
| EBIT | 49.05% | 57.81% | 71.27% | 170.25% | 645.00% |
| EBITDA | 53.60% | 54.46% | 55.49% | 98.74% | 191.33% |
| EPS Basic | 66.67% | 88.89% | 133.33% | 550.00% | 700.00% |
| Normalized Basic EPS | 40.00% | 50.00% | 66.67% | 150.00% | 400.00% |
| EPS Diluted | 66.67% | 88.89% | 133.33% | 550.00% | 700.00% |
| Normalized Diluted EPS | 40.00% | 50.00% | 66.67% | 150.00% | 400.00% |
| Average Basic Shares Outstanding | -1.52% | -0.69% | 0.10% | 0.11% | 0.12% |
| Average Diluted Shares Outstanding | -1.52% | -0.69% | 0.10% | 0.11% | 0.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |